Straumann (OTCMKTS:SAUHY) vs. Cooper Companies (NASDAQ:COO) Financial Review

Cooper Companies (NASDAQ:COO) and Straumann (OTCMKTS:SAUHY) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations.

Insider and Institutional Ownership

24.4% of Cooper Companies shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings and target prices for Cooper Companies and Straumann, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	1	7	8	1	2.53
Straumann	2	2	1	0	1.80

Cooper Companies currently has a consensus price target of $88.64, suggesting a potential upside of 45.22%. Given Cooper Companies’ stronger consensus rating and higher probable upside, equities analysts plainly believe Cooper Companies is more favorable than Straumann.

Valuation & Earnings

This table compares Cooper Companies and Straumann”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09 billion	2.91	$374.90 million	$2.02	30.22
Straumann	$3.14 billion	5.80	$429.59 million	N/A	N/A

Straumann has lower revenue, but higher earnings than Cooper Companies.

Profitability

This table compares Cooper Companies and Straumann’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cooper Companies	9.67%	10.34%	6.93%
Straumann	N/A	N/A	N/A

Volatility & Risk

Cooper Companies has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Comparatively, Straumann has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500.

Summary

Cooper Companies beats Straumann on 10 of the 13 factors compared between the two stocks.

About Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

About Straumann

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.